glp-1 drug names Costs Explained: Managing Coverage Challenges Letter: Association Between Incretin Mimetics

The treatment also improved motor function and extended the survival time of the Huntington's disease mice

Small molecule drug discovery at the glucagon-like peptide-1 receptor

It's important to note that endogenous GLP-1 is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4), giving it a very short half-life in circulation

GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) can cause fatigue through reduced caloric intake, gastrointestinal side effects, and metabolic adjustment

in clinical studies, an increase in hypoglycemia incidence was only observed in tirzepatide-treated patients if they had a comedication with insulin and/or oral insulinotropic agents (sulfonylurea) (61)

However, they are not the whole answer